Off-label drugs prescription in neonatology: A physician's duty or a medical hazardous attitude?

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue SUPPL. 1, 2011, Pages 99-100

  D'Aloja, Ernesto ^a   Paribello, Francesco ^a   Demontis, Roberto ^a   Müller, Mima ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Freedom to cure; Medical malpractice; Off label prescription; Responsibility

Indexed keywords

ARTICLE; CHILD SAFETY; HEALTH CARE NEED; HUMAN; INAPPROPRIATE PRESCRIBING; MALPRACTICE; MEDICAL DECISION MAKING; MEDICAL LIABILITY; NEONATOLOGY; NEWBORN INTENSIVE CARE; OFF LABEL DRUG USE; PATIENT AUTONOMY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; ADVERSE OUTCOME; CLINICAL PRACTICE; DISEASE ASSOCIATION; DRUG MARKETING; EUROPE; HEALTH CARE POLICY; MEDICAL INFORMATION; PHYSICAL DISEASE; PRACTICE GUIDELINE; RISK BENEFIT ANALYSIS;

ATTITUDE OF HEALTH PERSONNEL; FREEDOM; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALPRACTICE; MORAL OBLIGATIONS; NEONATOLOGY; OFF-LABEL USE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS;

EID: 80053292663     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.607574     Document Type: Article

References (10)

1. Sammons HM. Ethical consideration for clinical trials on medicinal products conducted in the paediatric population. Recommendations of the ad hoc group for the development of implementing guidelines for Directive 2001/20/EEC relating to good clinical practice in the conduct of clinical trials on medicinal products for human use. 2008. Available at: Http://ec.europa. eu/health/files/eudralex/vol-10/ethical-considerations-en. pdf, last access 8 june 2011
2. Neubert A, Wong IC, Bonifazi A, Catapano M, Felisi M, Baiardi P, Giaquinto C, et al. Defining off-label and unlicensed use of medicines for children: Results of a Delphi survey. Pharmacol Res 2008;58:316-322.
3. Cuzzolin L, Zaccaron A, Fanos V. Unlicensed and off-label uses of drugs in paediatrics: A review of the literature. Fundam Clin Pharmacol 2003;17:125-131. (Pubitemid 36241462)
4. Shah SS, Hall M, Goodman DM, Feuer P, Sharma V, Fargason C Jr, Hyman D, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med 2007;161:282-290. (Pubitemid 46364332)
5. Regulation (EC) n. 1902/2006 of the European Parliament and of the Council of 20 DecembeR 2006 amending Regulation 1901/2006 on medicinal products for paediatric use. Official Journal of the European Union 27.12.2006. L378/20-L378/1-L378/19.
6. Report on the survey of all paediatric uses of medicinal products in Europe, Established according to article 42-43 of Regulation (EC) No 1901/2006 of the European Parliament and of the Council on medicinal products for paediatric use. EMA/794083/2009, Available at Https:// ema.europa.eu/, Last access 8 June 2011.
7. Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr 2005;164:552-558. (Pubitemid 41225059)
8. Olsson J, Kimland E, Petterson S, Odlind V. Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care- a nationwide study. Accepted article; doi: 10.1111/j.1651-2227.2011.02287.x Acta Paediatrica 2011.
9. Mukattash T, Hawwa AF, Trew K, McElnay JC. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials. Eur J Clin Pharmacol 2011; 67:449-461.
10. Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther 2009;34:277-287.